| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.894 | 0.002 | 0.894 | 5 Hydroxytryptamine 3 antagonist | 0.706 0.002 CID_86580491 | ||
| 0.753 | 0.004 | 0.753 | 5 Hydroxytryptamine antagonist | 0.523 0.006 CID_86580491 | ||
| 0.581 | 0.004 | 0.581 | 5 Hydroxytryptamine uptake inhibitor | 0.357 0.005 CID_86580491 | ||
| 0.423 | 0.004 | 0.492 | Acetylcholine nicotinic antagonist | 0.492 0.004 CID_86580491 | CID_86580491 | |
| 0.418 | 0.004 | 0.418 | Dopamine uptake inhibitor | 0.312 0.004 CID_86580491 | ||
| 0.412 | 0.004 | 0.412 | Adrenaline uptake inhibitor | 0.241 0.005 CID_86580491 | ||
| 0.414 | 0.007 | 0.581 | Cholinergic antagonist | 0.581 0.004 CID_86580491 | CID_86580491 | |
| 0.413 | 0.007 | 0.578 | Acetylcholine antagonist | 0.578 0.004 CID_86580491 | CID_86580491 | |
| 0.439 | 0.038 | 0.439 | 5 Hydroxytryptamine release stimulant | 0.402 0.045 CID_86580491 | ||
| 0.407 | 0.021 | 0.487 | Psychostimulant | 0.487 0.012 CID_86580491 | CID_86580491 | |
| 0.435 | 0.059 | 0.435 | Calcium channel L-type activator | 0.414 0.072 CID_86580491 | ||
| 0.373 | 0.003 | 0.373 | Dopamine transporter inhibitor | 0.221 0.004 CID_86580491 | ||
| 0.347 | 0.052 | 0.347 | Calcium channel activator | 0.345 0.053 CID_86580491 | ||
| 0.346 | 0.076 | 0.408 | Vasodilator, peripheral | 0.408 0.053 CID_86580491 | CID_86580491 | |
| 0.303 | 0.048 | 0.303 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.25 | 0.004 | 0.382 | Nicotinic receptor alpha7 subunit antagonist | 0.382 0.003 CID_86580491 | CID_86580491 | |
| 0.37 | 0.129 | 0.37 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.333 0.171 CID_86580491 | ||
| 0.268 | 0.028 | 0.274 | Lipocortins synthesis antagonist | 0.274 0.027 CID_86580491 | CID_86580491 | |
| 0.289 | 0.052 | 0.289 | HERG channel blocker | |||
| 0.22 | 0.007 | 0.351 | Neuronal nicotinic receptor antagonist | 0.351 0.004 CID_86580491 | CID_86580491 | |
| 0.268 | 0.056 | 0.268 | 5 Hydroxytryptamine 1E antagonist | 0.231 0.096 CID_86580491 | ||
| 0.21 | 0.004 | 0.212 | 5 Hydroxytryptamine 3A antagonist | 0.212 0.004 CID_86580491 | CID_86580491 | |
| 0.193 | 0.016 | 0.205 | Antineoplastic alkaloid | 0.205 0.012 CID_86580491 | CID_86580491 | |
| 0.211 | 0.038 | 0.371 | Acetylcholine M1 receptor antagonist | 0.371 0.007 CID_86580491 | CID_86580491 | |
| 0.15 | 0.004 | 0.212 | 5 Hydroxytryptamine 3B antagonist | 0.212 0.003 CID_86580491 | CID_86580491 | |
| 0.16 | 0.018 | 0.177 | Prolactin inhibitor | 0.177 0.013 CID_86580491 | CID_86580491 | |
| 0.171 | 0.034 | 0.345 | Acetylcholine muscarinic antagonist | 0.345 0.006 CID_86580491 | CID_86580491 | |
| 0.153 | 0.018 | 0.167 | Acetylcholine M3 receptor agonist | 0.167 0.011 CID_86580491 | CID_86580491 | |
| 0.303 | 0.17 | 0.303 | Apoptosis agonist | 0.292 0.178 CID_86580491 | ||
| 0.136 | 0.011 | 0.162 | Glycine receptor antagonist | 0.162 0.005 CID_86580491 | CID_86580491 | |
| 0.124 | 0.005 | 0.134 | Nicotinic alpha3beta2 receptor antagonist | 0.134 0.004 CID_86580491 | CID_86580491 | |
| 0.185 | 0.075 | 0.185 | P-glycoprotein inhibitor | 0.185 0.075 CID_86580491 | ||
| 0.212 | 0.105 | 0.239 | DNA synthesis inhibitor | 0.239 0.075 CID_86580491 | CID_86580491 | |
| 0.144 | 0.039 | 0.144 | 5 Hydroxytryptamine 3A agonist | 0.104 0.071 CID_86580491 | ||
| 0.117 | 0.019 | 0.16 | Acetylcholine M4 receptor antagonist | 0.16 0.009 CID_86580491 | CID_86580491 | |
| 0.104 | 0.006 | 0.143 | 5 Hydroxytryptamine 4 antagonist | 0.143 0.004 CID_86580491 | CID_86580491 | |
| 0.207 | 0.114 | 0.439 | Spasmolytic | 0.439 0.033 CID_86580491 | CID_86580491 | |
| 0.108 | 0.019 | 0.241 | Acetylcholine M2 receptor antagonist | 0.241 0.005 CID_86580491 | CID_86580491 | |
| 0.184 | 0.096 | 0.184 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.108 | 0.025 | 0.108 | Nicotinic alpha4beta2 receptor antagonist | 0.102 0.03 CID_86580491 | ||
| 0.184 | 0.103 | 0.184 | Potassium channel blocker | |||
| 0.09 | 0.02 | 0.113 | Protein kinase C eta inhibitor | 0.113 0.014 CID_86580491 | CID_86580491 | |
| 0.146 | 0.076 | 0.163 | NOS3 expression enhancer | 0.163 0.061 CID_86580491 | CID_86580491 | |
| 0.204 | 0.145 | 0.204 | 5 Hydroxytryptamine uptake stimulant | 0.186 0.183 CID_86580491 | ||
| 0.092 | 0.04 | 0.108 | Somatostatin 1 agonist | 0.108 0.029 CID_86580491 | CID_86580491 | |
| 0.096 | 0.05 | 0.254 | Acetylcholine agonist | 0.254 0.008 CID_86580491 | CID_86580491 | |
| 0.069 | 0.024 | 0.072 | Prolactin release inhibitor | 0.072 0.02 CID_86580491 | CID_86580491 | |
| 0.062 | 0.018 | 0.062 | Nicotinic receptor alpha3 subunit antagonist | 0.052 0.024 CID_86580491 | ||
| 0.135 | 0.096 | 0.144 | Ca2+-transporting ATPase inhibitor | 0.144 0.058 CID_86580491 | CID_86580491 | |
| 0.058 | 0.023 | 0.058 | Nicotinic receptor alpha4 subunit antagonist | 0.058 0.023 CID_86580491 | ||
| 0.092 | 0.06 | 0.132 | Protein kinase C delta inhibitor | 0.132 0.03 CID_86580491 | CID_86580491 | |
| 0.066 | 0.035 | 0.113 | Acetylcholine M5 receptor antagonist | 0.113 0.014 CID_86580491 | CID_86580491 | |
| 0.039 | 0.011 | 0.041 | Protein kinase C beta I inhibitor | 0.041 0.008 CID_86580491 | CID_86580491 | |
| 0.106 | 0.079 | 0.136 | Adenylate cyclase inhibitor | 0.136 0.055 CID_86580491 | CID_86580491 | |
| 0.044 | 0.019 | 0.071 | Farnesoid X receptor agonist | 0.071 0.007 CID_86580491 | CID_86580491 | |
| 0.044 | 0.019 | 0.044 | Nicotinic receptor beta4 subunit antagonist | 0.043 0.02 CID_86580491 | ||
| 0.1 | 0.077 | 0.142 | Protein kinase C gamma inhibitor | 0.142 0.037 CID_86580491 | CID_86580491 | |
| 0.146 | 0.125 | 0.199 | Angiogenesis stimulant | 0.199 0.095 CID_86580491 | CID_86580491 | |
| 0.145 | 0.126 | 0.158 | Antimitotic | 0.158 0.113 CID_86580491 | CID_86580491 | |
| 0.08 | 0.061 | 0.08 | Ca(v)3.1 blocker | |||
| 0.056 | 0.04 | 0.06 | Acetyl-CoA transferase 2 inhibitor | 0.06 0.031 CID_86580491 | CID_86580491 | |
| 0.033 | 0.018 | 0.033 | Dipeptidyl peptidase I inhibitor | 0.032 0.019 CID_86580491 | ||
| 0.076 | 0.062 | 0.158 | Acetylcholine nicotinic agonist | 0.158 0.015 CID_86580491 | CID_86580491 | |
| 0.052 | 0.04 | 0.064 | Acetylcholine M2 receptor agonist | 0.064 0.024 CID_86580491 | CID_86580491 | |
| 0.222 | 0.211 | 0.306 | Analgesic | 0.306 0.137 CID_86580491 | CID_86580491 | |
| 0.122 | 0.112 | 0.126 | Sigma receptor agonist | 0.126 0.107 CID_86580491 | CID_86580491 | |
| 0.044 | 0.035 | 0.048 | Microtubule stabilization | 0.048 0.031 CID_86580491 | CID_86580491 | |
| 0.074 | 0.068 | 0.084 | Opioid kappa receptor antagonist | 0.084 0.052 CID_86580491 | CID_86580491 | |
| 0.123 | 0.117 | 0.136 | Adenylate cyclase stimulant | 0.136 0.088 CID_86580491 | CID_86580491 | |
| 0.054 | 0.049 | 0.078 | Androgen agonist | 0.078 0.025 CID_86580491 | CID_86580491 | |
| 0.031 | 0.027 | 0.035 | Protein kinase C beta II inhibitor | 0.035 0.018 CID_86580491 | CID_86580491 | |
| 0.053 | 0.051 | 0.163 | Acetylcholine M3 receptor antagonist | 0.163 0.01 CID_86580491 | CID_86580491 | |
| 0.043 | 0.042 | 0.046 | 5 Hydroxytryptamine 1 agonist | 0.046 0.04 CID_86580491 | CID_86580491 | |
| 0.089 | 0.089 | 0.114 | Adenylate kinase inhibitor | 0.114 0.049 CID_86580491 | CID_86580491 | |
| 0.022 | 0.025 | 0.028 | 5 Hydroxytryptamine 4 agonist | 0.028 0.01 CID_86580491 | CID_86580491 | |
| 0.095 | 0.101 | 0.105 | Microtubule formation inhibitor | 0.105 0.083 CID_86580491 | CID_86580491 | |
| 0.08 | 0.086 | 0.083 | Protein kinase C zeta inhibitor | 0.083 0.079 CID_86580491 | CID_86580491 | |
| 0.029 | 0.036 | 0.037 | Somatostatin 5 agonist | 0.037 0.021 CID_86580491 | CID_86580491 | |
| 0.027 | 0.04 | 0.034 | Somatostatin 1 antagonist | 0.034 0.031 CID_86580491 | CID_86580491 | |
| 0.207 | 0.221 | 0.33 | Antibacterial | 0.33 0.114 CID_86580491 | CID_86580491 | |
| 0.057 | 0.075 | 0.083 | Protein kinase C beta inhibitor | 0.083 0.026 CID_86580491 | CID_86580491 | |
| 0.049 | 0.067 | 0.071 | 5 Hydroxytryptamine agonist | 0.071 0.046 CID_86580491 | CID_86580491 | |
| 0.111 | 0.136 | 0.126 | Growth hormone agonist | 0.126 0.111 CID_86580491 | CID_86580491 | |
| 0.038 | 0.065 | 0.083 | Nicotinic neuronal receptor agonist | 0.083 0.019 CID_86580491 | CID_86580491 | |
| 0.082 | 0.11 | 0.097 | Nav1.4 sodium channel blocker | 0.097 0.08 CID_86580491 | CID_86580491 | |
| 0.038 | 0.069 | 0.052 | Nicotinic alpha7 receptor agonist | 0.052 0.039 CID_86580491 | CID_86580491 | |
| 0.02 | 0.052 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 CID_86580491 | CID_86580491 | |
| 0.026 | 0.058 | 0.04 | Substance P antagonist | 0.04 0.026 CID_86580491 | CID_86580491 | |
| 0.028 | 0.061 | 0.041 | Neurokinin 1 antagonist | 0.041 0.027 CID_86580491 | CID_86580491 | |
| 0.146 | 0.18 | 0.234 | Cardiotonic | 0.234 0.093 CID_86580491 | CID_86580491 | |
| 0.079 | 0.115 | 0.092 | Beta glucuronidase inhibitor | 0.092 0.084 CID_86580491 | CID_86580491 | |
| 0.062 | 0.103 | 0.094 | Opioid antagonist | 0.094 0.053 CID_86580491 | CID_86580491 | |
| 0.014 | 0.057 | 0.035 | Acetylcholine M4 receptor agonist | 0.035 0.017 CID_86580491 | CID_86580491 | |
| 0.034 | 0.077 | 0.124 | Acetylcholine muscarinic agonist | 0.124 0.013 CID_86580491 | CID_86580491 | |
| 0.055 | 0.1 | 0.073 | Glycine receptor agonist | 0.073 0.049 CID_86580491 | CID_86580491 | |
| 0.177 | 0.222 | 0.251 | Sodium/bile acid cotransporter inhibitor | 0.251 0.127 CID_86580491 | CID_86580491 | |
| 0.031 | 0.077 | 0.048 | Neurokinin antagonist | 0.048 0.037 CID_86580491 | CID_86580491 | |
| 0.075 | 0.121 | 0.097 | DNA polymerase I inhibitor | 0.097 0.089 CID_86580491 | CID_86580491 | |
| 0.023 | 0.074 | 0.1 | Acetylcholine M1 receptor agonist | 0.1 0.012 CID_86580491 | CID_86580491 | |
| 0.074 | 0.125 | 0.111 | AMP-activated protein kinase stimulant | 0.111 0.058 CID_86580491 | CID_86580491 | |
| 0.172 | 0.226 | 0.196 | Apoptosis antagonist | 0.196 0.184 CID_86580491 | CID_86580491 | |
| 0.009 | 0.069 | 0.04 | Nociceptin (N/OFQ) receptor antagonist | 0.04 0.021 CID_86580491 | CID_86580491 | |
| 0.01 | 0.08 | 0.036 | Cholecystokinin A antagonist | 0.036 0.027 CID_86580491 | CID_86580491 | |
| 0.008 | 0.08 | 0.027 | Cholecystokinin B antagonist | 0.027 0.025 CID_86580491 | CID_86580491 | |
| 0.011 | 0.089 | 0.043 | Cholecystokinin antagonist | 0.043 0.028 CID_86580491 | CID_86580491 | |
| 0.161 | 0.269 | 0.206 | Interleukin 2 agonist | 0.206 0.178 CID_86580491 | CID_86580491 | |
| 0.095 | 0.23 | 0.164 | Platelet antagonist | 0.164 0.13 CID_86580491 | CID_86580491 | |
| 0.109 | 0.248 | 0.208 | Cyclic AMP phosphodiesterase inhibitor | 0.208 0.088 CID_86580491 | CID_86580491 | |
| 0.07 | 0.217 | 0.208 | Cholinergic | 0.208 0.043 CID_86580491 | CID_86580491 | |
| 0.129 | 0.308 | 0.312 | Antiobesity | 0.312 0.108 CID_86580491 | CID_86580491 | |
| 0.079 | 0.289 | 0.164 | Tumour necrosis factor alpha release inhibitor | 0.164 0.14 CID_86580491 | CID_86580491 | |
| 0.033 | 0.273 | 0.13 | Bronchodilator | 0.13 0.039 CID_86580491 | CID_86580491 | |
| 0.074 | 0.393 | 0.216 | Immunosuppressant | 0.216 0.18 CID_86580491 | CID_86580491 | |
| 0.061 | 0.515 | 0.531 | Toll-Like receptor 7 agonist | 0.531 0.026 CID_86580491 | CID_86580491 | |
| 0.058 | 0.526 | 0.525 | Toll-Like receptor agonist | 0.525 0.027 CID_86580491 | CID_86580491 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |